Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Travel credit card points can significantly reduce your travel costs. Learn how to leverage their value for your next trip.
23,657 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
When a beloved fantasy IP meets a streaming giant, the financial narrative changes as quickly as a plot twist. This a...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
One rental property changed everything for a seasoned investor. This article reveals the smart loans, disciplined hab...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
Gold rallied as market chatter around with iran sending gold stoked safe-haven demand. Investors are weighing how thi...
SNDL investors are keenly watching Q4 2025 earnings for a read on revenue mix, cost discipline, and debt strategy. Th...
Tech Mahindra's Mohit Joshi says AI will transform jobs, not vanish them. This piece surveys how IT services leaders ...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
Star Group's Q2 2026 results shed light on the company's path to profitability and growth. This article breaks down t...
Learn how to analyze Baer’s Q1 2026 earnings call. This guide breaks down the numbers, guidance, and what it means fo...
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...